Revenue must have begun in December so should be on upcoming 10-k, then expanded in Q1 which ends next week.. I cant find any info on what royalty , license or monies they receive per procedure. So hard to judge revenue ramp rate..
Seems like they have a few debts to pay but also are at a point to bring in significant investment to expand reach with their approved ED stem cell therapy as well as expand other technology..
Less than 1 million market cap seems way off here even with some minor dilution. I think this blows by .01 or .02 very soon with any kind of awareness growing.. my question is this one that has .05-.10 in it soon?? Can’t find enough info to suggest that yet..
News 
Market Data 
Discover 
AI
